MedTrace Logo

Efficacy and Safety Study of Total Flavonoids of Propolis Dropping Pill to Treat Angina Pectoris

NCT01453582 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 478

Last updated 2018-02-07

No results posted yet for this study

Summary

The purpose of this study is to confirm the efficacy and safety of total flavonoids of propolis dropping pill to treat angina pectoris, evaluated by total exercise time of treadmill exercise test.

Conditions

  • Stable Angina Pectoris

Interventions

DRUG

Total Flavonoids of Propolis dropping pill

One pack contains 30 pills, weight 33g. One pack each time, three times a day, 14 days a course.

DRUG

total Flavonoids of Propolis dropping pill

One pack contains 30 pills, weight 33g. One pack each time, three times a day, 14 days a course.

Sponsors & Collaborators

  • Shanghai Greenvalley Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Lanjun Sun · Sencond Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-06-30
Completion
2015-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01453582 on ClinicalTrials.gov